Efectividad y duración de la inmunidad de la vacuna frente al meningococo serogrupo A y C

dc.contributor.authorLuis García Comas
dc.contributor.authorRosa Ramírez Fernández
dc.contributor.authorRosario Castañeda López
dc.contributor.authorJuan Carlos Sanz
dc.contributor.authorJulio A. Vázquez
dc.contributor.authorMa Dolores Lasheras Carbajo
dc.contributor.authorDolores Barranco Ordóñez
dc.contributor.authorJesús Ruíz-Contreras
dc.contributor.authorJosé Jover Ibarra
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T16:43:20Z
dc.date.available2026-03-22T16:43:20Z
dc.date.issued2000
dc.descriptionCitaciones: 1
dc.description.abstractThe response measured by means of total antibodies contradicts the clinical response to the vaccination and the measurement by means of bactericidal antibodies underestimates the protection if it is compared with the results of vaccinal efficacy, for which reason, we need to search for biological indicators that would correlate adequately with the clinical response following immunisation.
dc.identifier.doi10.1590/s1135-57272000000400015
dc.identifier.urihttps://doi.org/10.1590/s1135-57272000000400015
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/59916
dc.language.isoes
dc.publisherMinistry of Health of Spain
dc.relation.ispartofRevista Española de Salud Pública
dc.sourceDireccion General de Epidemiologia
dc.subjectMedicine
dc.subjectHumanities
dc.titleEfectividad y duración de la inmunidad de la vacuna frente al meningococo serogrupo A y C
dc.typearticle

Files